HKSE - Delayed Quote HKD

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)

Compare
13.300
-0.040
(-0.30%)
At close: 4:08:28 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
3,939,213.932
3,414,217.064
4,217,570.893
3,937,814.791
2,579,774.350
Operating Cash Flow
--
3,414,217.064
4,217,570.893
3,937,814.791
2,579,774.350
Investing Cash Flow
-2,974,709.811
-3,819,290.372
-4,064,038.161
-3,857,489.196
-4,706,228.717
Financing Cash Flow
-1,441,959.607
-1,336,249.799
4,428,474.734
-819,407.187
1,467,129.083
End Cash Position
9,604,707.323
9,502,388.906
11,170,066.989
6,459,717.065
7,324,881.260
Capital Expenditure
-4,146,156.042
-5,336,704.753
-5,888,838.857
-4,972,799.402
-4,437,119.049
Issuance of Debt
26,864,048.353
23,175,941.311
30,027,528.719
29,202,760.470
17,961,360.471
Repayment of Debt
-27,399,280.868
-21,146,225.034
-26,280,140.581
-27,391,947.903
-15,707,759.261
Free Cash Flow
-206,942.110
-1,922,487.690
-1,671,267.964
-1,034,984.611
-1,857,344.699
12/31/2020 - 10/30/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers